Literature DB >> 6754868

Kindling and carbamazepine in affective illness.

R M Post, T W Uhde, F W Putnam, J C Ballenger, W H Berrettini.   

Abstract

Kindling represents a process in which increasing behavioral and convulsive responses occur to repetition of the same stimulus over time. Increased behavioral response can also occur to repetition of the same dose of psychomotor stimulant or dopamine agonist, i.e., behavioral sensitization. These two models, which may have important implications for the progressive development of psychopathology in a variety of neuropsychiatric syndromes, are reviewed. Carbamazepine, a drug of choice in treatment of temporal lobe and limbic seizures and effective in inhibiting kindling, has been used as a treatment of primary and secondary affective illness. The efficacy of carbamazepine in affective illness and its clinical and theoretical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754868     DOI: 10.1097/00005053-198212000-00002

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  15 in total

1.  Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder.

Authors:  Hilary P Blumberg; Nelson H Donegan; Charles A Sanislow; Susan Collins; Cheryl Lacadie; Pawel Skudlarski; Ralitza Gueorguieva; Robert K Fulbright; Thomas H McGlashan; John C Gore; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2005-10-26       Impact factor: 4.530

Review 2.  Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement.

Authors:  Todd D Gould; Haim Einat
Journal:  Neurosci Biobehav Rev       Date:  2007-05-31       Impact factor: 8.989

Review 3.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 4.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

Review 5.  Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Authors:  Robert M Post; Terence A Ketter; Thomas Uhde; James C Ballenger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder.

Authors:  Jared W Young; Zackary A Cope; Benedetto Romoli; Esther Schrurs; Jordy van Enkhuizen; Richard F Sharp; Davide Dulcis
Journal:  Neuropsychopharmacology       Date:  2018-02-27       Impact factor: 7.853

7.  Response of carbamzepine in bipolar disorder: kindlers versus non-kindlers.

Authors:  Subhash Chandra Das; Subhash Chandra Gupta; Soumya Basu; Daya Ram
Journal:  Indian J Psychiatry       Date:  2002-07       Impact factor: 1.759

8.  Adolecsent mania, EEG abnormality and response to anticonvulsants: a three - year follow-up study.

Authors:  T K Aich; V K Sinha; H S Nizami
Journal:  Indian J Psychiatry       Date:  2001-07       Impact factor: 1.759

Review 9.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

10.  Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder.

Authors:  Hilary P Blumberg; Carolyn Fredericks; Fei Wang; Jessica H Kalmar; Linda Spencer; Xenophon Papademetris; Brian Pittman; Andres Martin; Bradley S Peterson; Robert K Fulbright; John H Krystal
Journal:  Bipolar Disord       Date:  2005-12       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.